REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.76
-0.03 (-0.34%)
Nov 4, 2024, 4:00 PM EST - Market closed
REGENXBIO Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 89.04 | 90.24 | 112.72 | 470.35 | 154.57 | 35.23 | Upgrade
|
| Revenue | 89.04 | 90.24 | 112.72 | 470.35 | 154.57 | 35.23 | Upgrade
|
| Revenue Growth (YoY) | -8.18% | -19.94% | -76.03% | 204.30% | 338.70% | -83.88% | Upgrade
|
| Cost of Revenue | 265.81 | 266.48 | 287.8 | 233.27 | 202.01 | 132.43 | Upgrade
|
| Gross Profit | -176.76 | -176.24 | -175.07 | 237.08 | -47.44 | -97.19 | Upgrade
|
| Selling, General & Admin | 78.61 | 87.79 | 85.28 | 79.33 | 63.82 | 51.82 | Upgrade
|
| Other Operating Expenses | 0.33 | 0.4 | -14.18 | 0.33 | 0.3 | - | Upgrade
|
| Operating Expenses | 66.2 | 88.19 | 71.1 | 77.1 | 71.79 | 51.81 | Upgrade
|
| Operating Income | -242.96 | -264.43 | -246.18 | 159.98 | -119.23 | -149 | Upgrade
|
| Interest Expense | -5.41 | -6.86 | -23.25 | -26.28 | -0.77 | - | Upgrade
|
| Interest & Investment Income | 12.94 | 11.34 | 5.73 | 7.54 | 13.99 | 51.51 | Upgrade
|
| EBT Excluding Unusual Items | -235.43 | -259.95 | -263.71 | 141.25 | -106.01 | -97.49 | Upgrade
|
| Merger & Restructuring Charges | -3.7 | -3.7 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -16.7 | - | - | - | Upgrade
|
| Pretax Income | -241.23 | -263.65 | -280.41 | 141.25 | -106.01 | -97.49 | Upgrade
|
| Income Tax Expense | -0.15 | -0.15 | -0.08 | 13.41 | 5.24 | -2.76 | Upgrade
|
| Net Income | -241.08 | -263.49 | -280.32 | 127.84 | -111.25 | -94.73 | Upgrade
|
| Net Income to Common | -241.08 | -263.49 | -280.32 | 127.84 | -111.25 | -94.73 | Upgrade
|
| Shares Outstanding (Basic) | 46 | 44 | 43 | 42 | 37 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 46 | 44 | 43 | 44 | 37 | 37 | Upgrade
|
| Shares Change (YoY) | 6.20% | 1.35% | -1.73% | 17.79% | 1.61% | 0.11% | Upgrade
|
| EPS (Basic) | -5.23 | -6.02 | -6.50 | 3.01 | -2.98 | -2.58 | Upgrade
|
| EPS (Diluted) | -5.23 | -6.02 | -6.50 | 2.91 | -2.98 | -2.58 | Upgrade
|
| Free Cash Flow | -194.72 | -228.37 | -238.21 | 134.7 | -80.93 | -119.43 | Upgrade
|
| Free Cash Flow Per Share | -4.23 | -5.22 | -5.52 | 3.07 | -2.17 | -3.25 | Upgrade
|
| Gross Margin | -198.51% | -195.29% | -155.31% | 50.40% | -30.69% | -275.86% | Upgrade
|
| Operating Margin | -272.86% | -293.02% | -218.39% | 34.01% | -77.14% | -422.89% | Upgrade
|
| Profit Margin | -270.74% | -291.99% | -248.68% | 27.18% | -71.98% | -268.88% | Upgrade
|
| Free Cash Flow Margin | -218.67% | -253.06% | -211.32% | 28.64% | -52.36% | -338.96% | Upgrade
|
| EBITDA | -226.02 | -247.11 | -233.27 | 169.54 | -110.83 | -141.85 | Upgrade
|
| EBITDA Margin | -253.83% | -273.83% | -206.94% | 36.05% | -71.70% | - | Upgrade
|
| D&A For EBITDA | 16.94 | 17.32 | 12.91 | 9.56 | 8.41 | 7.15 | Upgrade
|
| EBIT | -242.96 | -264.43 | -246.18 | 159.98 | -119.23 | -149 | Upgrade
|
| EBIT Margin | -272.86% | -293.02% | -218.39% | 34.01% | -77.14% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 9.49% | - | - | Upgrade
|
| Revenue as Reported | 89.04 | 90.24 | 112.72 | 470.35 | 154.57 | 35.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.